118 related articles for article (PubMed ID: 11502905)
1. Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism.
Graf WD; Unis AS; Yates CM; Sulzbacher S; Dinulos MB; Jack RM; Dugaw KA; Paddock MN; Parson WW
Neurology; 2001 Aug; 57(3):410-6. PubMed ID: 11502905
[TBL] [Abstract][Full Text] [Related]
2. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
[TBL] [Abstract][Full Text] [Related]
3. A gender-moderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo-cardio-facial syndrome (22q11.2 deletion syndrome).
Kates WR; Antshel KM; Abdulsabur N; Colgan D; Funke B; Fremont W; Higgins AM; Kucherlapati R; Shprintzen RJ
Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):274-80. PubMed ID: 16511839
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
[TBL] [Abstract][Full Text] [Related]
5. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome.
Bearden CE; Jawad AF; Lynch DR; Monterossso JR; Sokol S; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
Child Neuropsychol; 2005 Feb; 11(1):109-17. PubMed ID: 15846854
[TBL] [Abstract][Full Text] [Related]
6. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.
Lachman HM; Morrow B; Shprintzen R; Veit S; Parsia SS; Faedda G; Goldberg R; Kucherlapati R; Papolos DF
Am J Med Genet; 1996 Sep; 67(5):468-72. PubMed ID: 8886163
[TBL] [Abstract][Full Text] [Related]
7. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome.
Bearden CE; Jawad AF; Lynch DR; Sokol S; Kanes SJ; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
Am J Psychiatry; 2004 Sep; 161(9):1700-2. PubMed ID: 15337663
[TBL] [Abstract][Full Text] [Related]
8. IQ and hemizygosity for the Val
Franconi CP; McDonald-McGinn D; Zackai EH; McNamara MA; Salmons H; Moss E; Gur RE; Devoto M; Emanuel BS
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1112-1115. PubMed ID: 27619075
[TBL] [Abstract][Full Text] [Related]
9. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.
Michaelovsky E; Gothelf D; Korostishevsky M; Frisch A; Burg M; Carmel M; Steinberg T; Inbar D; Apter A; Weizman A
Int J Neuropsychopharmacol; 2008 May; 11(3):351-63. PubMed ID: 17949513
[TBL] [Abstract][Full Text] [Related]
10. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
Baker K; Baldeweg T; Sivagnanasundaram S; Scambler P; Skuse D
Biol Psychiatry; 2005 Jul; 58(1):23-31. PubMed ID: 15935994
[TBL] [Abstract][Full Text] [Related]
11. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome.
Shashi V; Keshavan MS; Howard TD; Berry MN; Basehore MJ; Lewandowski E; Kwapil TR
Clin Genet; 2006 Mar; 69(3):234-8. PubMed ID: 16542388
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome.
Takarae Y; Schmidt L; Tassone F; Simon TJ
Cogn Affect Behav Neurosci; 2009 Mar; 9(1):83-90. PubMed ID: 19246329
[TBL] [Abstract][Full Text] [Related]
13. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele.
Papolos DF; Veit S; Faedda GL; Saito T; Lachman HM
Mol Psychiatry; 1998 Jul; 3(4):346-9. PubMed ID: 9702745
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder.
Lachman HM; Kelsoe J; Moreno L; Katz S; Papolos DF
Psychiatr Genet; 1997; 7(1):13-7. PubMed ID: 9264133
[TBL] [Abstract][Full Text] [Related]
15. Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report.
Dávila R; Zumárraga M; Basterreche N; Arrúe A; Zamalloa MI; Anguiano JB
J Affect Disord; 2006 Jun; 92(2-3):277-81. PubMed ID: 16542735
[TBL] [Abstract][Full Text] [Related]
16. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.
Gothelf D; Eliez S; Thompson T; Hinard C; Penniman L; Feinstein C; Kwon H; Jin S; Jo B; Antonarakis SE; Morris MA; Reiss AL
Nat Neurosci; 2005 Nov; 8(11):1500-2. PubMed ID: 16234808
[TBL] [Abstract][Full Text] [Related]
17. Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes.
Radoeva PD; Coman IL; Salazar CA; Gentile KL; Higgins AM; Middleton FA; Antshel KM; Fremont W; Shprintzen RJ; Morrow BE; Kates WR
Psychiatr Genet; 2014 Dec; 24(6):269-72. PubMed ID: 25325218
[TBL] [Abstract][Full Text] [Related]
18. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients.
Zumárraga M; Arrúe A; Basterreche N; Macías I; Catalán A; Madrazo A; Bustamante S; Zamalloa MI; Erkoreka L; Gordo E; Arnaiz A; Olivas O; Arroita A; Marín E; González-Torres MA
Pharmacogenomics; 2016 Jun; 17(8):837-51. PubMed ID: 27269044
[TBL] [Abstract][Full Text] [Related]
19. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior.
Gogos JA; Morgan M; Luine V; Santha M; Ogawa S; Pfaff D; Karayiorgou M
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9991-6. PubMed ID: 9707588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
